Sodium/glucose cotransporter 2/ja: Difference between revisions
Sodium/glucose cotransporter 2/ja
Created page with "== 糖尿病治療薬SGLT2阻害薬 == {{Anchor|SGLT2 inhibitors for diabetes}} {{Main/ja|SGLT2 inhibitor/ja}} SGLT2阻害薬は、グリフロジンまたはフロジンとも呼ばれる。SGLT2阻害薬は血糖値を低下させるため、2型糖尿病の治療に使用される可能性がある。グリフロジンは血糖コントロールを高めるだけでなく、体重や収縮期およ..." Tags: Mobile edit Mobile web edit |
No edit summary Tags: Mobile edit Mobile web edit |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 16: | Line 16: | ||
{{Anchor|Clinical significance}} | {{Anchor|Clinical significance}} | ||
この遺伝子の変異は[[renal glycosuria/ja|腎性糖尿症]]とも関連している。 | |||
== こちらも参照 == | |||
* [[SGLT/ja|SGLT]]ファミリー | |||
* [[SGLT]] | * [[Discovery and development of gliflozins/ja|グリフロジンの発見と開発]] | ||
* [[Discovery and development of gliflozins]] | * [[Phlorizin/ja|フロリジン]] — [[SLC5A1/ja|SGLT1]]および[[SGLT2/ja|SGLT2]]の競合的阻害薬である。 | ||
* [[Phlorizin]] — | |||
== References == | == References == | ||
{{reflist|33em}} | {{reflist|33em}} | ||
== さらに読む == | |||
{{refbegin|33em}} | {{refbegin|33em}} | ||
* {{cite journal | vauthors = van den Heuvel LP, Assink K, Willemsen M, Monnens L | title = Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2) | journal = Human Genetics | volume = 111 | issue = 6 | pages = 544–7 | date = Dec 2002 | pmid = 12436245 | doi = 10.1007/s00439-002-0820-5 | s2cid = 28089635 }} | * {{cite journal | vauthors = van den Heuvel LP, Assink K, Willemsen M, Monnens L | title = Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2) | journal = Human Genetics | volume = 111 | issue = 6 | pages = 544–7 | date = Dec 2002 | pmid = 12436245 | doi = 10.1007/s00439-002-0820-5 | s2cid = 28089635 }} | ||
| Line 43: | Line 36: | ||
* {{cite journal | vauthors = Castaneda F, Burse A, Boland W, Kinne RK | title = Thioglycosides as inhibitors of hSGLT1 and hSGLT2: potential therapeutic agents for the control of hyperglycemia in diabetes | journal = International Journal of Medical Sciences | volume = 4 | issue = 3 | pages = 131–9 | year = 2007 | pmid = 17505558 | pmc = 1868657 | doi = 10.7150/ijms.4.131 }} | * {{cite journal | vauthors = Castaneda F, Burse A, Boland W, Kinne RK | title = Thioglycosides as inhibitors of hSGLT1 and hSGLT2: potential therapeutic agents for the control of hyperglycemia in diabetes | journal = International Journal of Medical Sciences | volume = 4 | issue = 3 | pages = 131–9 | year = 2007 | pmid = 17505558 | pmc = 1868657 | doi = 10.7150/ijms.4.131 }} | ||
{{refend}} | {{refend}} | ||
{{Solute carrier family/ja|bg|bg0}} | |||
{{Solute carrier family|bg|bg0}} | {{Sodium-glucose transporter modulators/ja}} | ||
{{Sodium-glucose transporter modulators}} | |||
[[Category:Solute carrier family]] | [[Category:Solute carrier family]] | ||
[[Category:Genes mutated in mice]] | [[Category:Genes mutated in mice]] | ||